[1]
“THE IMPACT OF TERLIPRESSIN ON HEPATORENEAL DISEASE: RESULTS OF AN OBSERVATIONAL, DESCRIPTIVE, AND CROSS-SECTIONAL STUDY DISEASE”, Journal of Pharmaceutical Negative Results, pp. 2320–2326, Dec. 2022, doi: 10.47750/pnr.2022.13.S04.286.